Universal Ibogaine Inc. (TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce...
Small Pharma ($TSXV:DMT) CEO, George Tziras, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments. George initially...
In this important episode of Mindshifting Moments, Margaret Williamson is joined by Yuriy Blokhin of Homecoming Health. During this conversation, the two...
Yeast is not the simple single-celled microorganism we once thought, but a competitive killer. When starved of glucose, yeast releases a toxin that will...
Big Pharma feeling pressure to join forces with psychedelics firms to develop mental health treatments The post Can Psychedelics Solve Big Pharma’s Mental...
Who came up with what? It is the question that has been sparking endless controversy in the psychedelic industry lately. The groundwork of the science,...
The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy The post Enosis and OVID Clinics offer...
The companies claim this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy The post Enosis and Ovid Clinics partner...
FCM MM Holdings, one of Mind Medicine’s (NEO: MMED) shareholders with a 6.1% stake, has formally filed a complaint with The post Activist Investor Calls...
Company is expanding clinical trials of its psilocybin-based medicine. The post Compass Pathways Losses Tick Up on Increased R&D appeared first on...